Sequoia Financial Advisors LLC Grows Position in Kenvue Inc. $KVUE

Sequoia Financial Advisors LLC lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 4.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,226 shares of the company’s stock after purchasing an additional 1,273 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Kenvue were worth $570,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Almanack Investment Partners LLC. acquired a new stake in shares of Kenvue during the second quarter worth $221,000. CWM LLC boosted its holdings in shares of Kenvue by 6.6% during the second quarter. CWM LLC now owns 31,265 shares of the company’s stock worth $654,000 after purchasing an additional 1,923 shares during the last quarter. OFI Invest Asset Management boosted its holdings in shares of Kenvue by 705.6% during the second quarter. OFI Invest Asset Management now owns 26,979 shares of the company’s stock worth $565,000 after purchasing an additional 23,630 shares during the last quarter. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Kenvue by 4.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 230,999 shares of the company’s stock worth $4,847,000 after purchasing an additional 9,660 shares during the last quarter. Finally, Concurrent Investment Advisors LLC boosted its holdings in shares of Kenvue by 30.5% during the second quarter. Concurrent Investment Advisors LLC now owns 75,883 shares of the company’s stock worth $1,588,000 after purchasing an additional 17,748 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the topic of several analyst reports. JPMorgan Chase & Co. decreased their price objective on Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. Bank of America reduced their target price on Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Royal Bank Of Canada reduced their target price on Kenvue from $24.00 to $22.00 and set a “sector perform” rating on the stock in a report on Friday, August 8th. Barclays reduced their target price on Kenvue from $20.00 to $17.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Finally, Canaccord Genuity Group reduced their target price on Kenvue from $29.00 to $26.00 and set a “buy” rating on the stock in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus price target of $21.18.

Kenvue Trading Up 8.4%

Shares of KVUE opened at $15.30 on Monday. The stock’s 50-day moving average is $18.54 and its two-hundred day moving average is $21.02. The stock has a market cap of $29.37 billion, a PE ratio of 20.68, a P/E/G ratio of 2.20 and a beta of 0.72. Kenvue Inc. has a 12 month low of $14.05 and a 12 month high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion for the quarter, compared to analysts’ expectations of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm’s quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.4%. Kenvue’s dividend payout ratio is presently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.